Processa Pharmaceuticals Inc (PCSA)
2.52
+0.17
(+7.23%)
USD |
NASDAQ |
May 07, 16:00
2.52
0.00 (0.00%)
After-Hours: 20:00
Processa Pharmaceuticals Cash from Operations (Quarterly): -2.124M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.124M |
| September 30, 2023 | -1.761M |
| June 30, 2023 | -2.064M |
| March 31, 2023 | -2.114M |
| December 31, 2022 | -2.497M |
| September 30, 2022 | -2.974M |
| June 30, 2022 | -2.330M |
| March 31, 2022 | -1.803M |
| December 31, 2021 | -2.727M |
| September 30, 2021 | -1.553M |
| June 30, 2021 | -2.194M |
| March 31, 2021 | -2.244M |
| December 31, 2020 | -2.275M |
| September 30, 2020 | 0.0292M |
| June 30, 2020 | -0.3506M |
| March 31, 2020 | -0.5465M |
| December 31, 2019 | -0.6135M |
| September 30, 2019 | -0.7218M |
| June 30, 2019 | -0.8075M |
| March 31, 2019 | -0.6074M |
| December 31, 2018 | -0.464M |
| September 30, 2018 | -1.011M |
| June 30, 2018 | -1.164M |
| March 31, 2018 | -1.069M |
| Date | Value |
|---|---|
| December 31, 2017 | -1.405M |
| September 30, 2017 | -0.1737M |
| June 30, 2017 | -0.0747M |
| March 31, 2017 | -0.0016M |
| December 31, 2016 | -0.007M |
| September 30, 2016 | 0.0167M |
| June 30, 2016 | -0.0026M |
| March 31, 2016 | -0.0504M |
| December 31, 2015 | -0.0461M |
| September 30, 2015 | -0.0472M |
| June 30, 2015 | -0.2765M |
| March 31, 2015 | -0.5021M |
| December 31, 2014 | -0.4556M |
| September 30, 2014 | -0.5402M |
| June 30, 2014 | -0.7081M |
| March 31, 2014 | -0.9877M |
| December 31, 2013 | -0.4625M |
| September 30, 2013 | -0.7093M |
| June 30, 2013 | -0.7739M |
| March 31, 2013 | -0.593M |
| December 31, 2012 | -0.6478M |
| September 30, 2012 | -0.6562M |
| June 30, 2012 | -0.3922M |
| March 31, 2012 | -0.1962M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-2.974M
Minimum
Sep 2022
0.0292M
Maximum
Sep 2020
-1.667M
Average
-2.064M
Median
Jun 2023
Cash from Operations (Quarterly) Benchmarks
| DIH Holding US Inc | -- |
| NovaBay Pharmaceuticals Inc | -0.314M |
| Palatin Technologies Inc | -10.48M |
| iBio Inc | -4.706M |
| Theriva Biologics Inc | -6.541M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | -0.0306M |
| Free Cash Flow | -8.066M |
| Free Cash Flow Per Share (Quarterly) | -1.508 |
| Free Cash Flow Yield | -244.2% |